News
A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...
Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results